Clover Health Investments, Corp.
CLOV
$0.6445
$0.00170.26%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -43.34% | -19.98% | 10.80% | 54.68% | 162.35% |
| Total Other Revenue | -4.08% | 11.40% | 10.27% | -31.64% | 322.82% |
| Total Revenue | -43.11% | -19.79% | 10.80% | 53.94% | 162.93% |
| Cost of Revenue | -48.57% | -25.99% | 1.70% | 39.40% | 122.67% |
| Gross Profit | 107.10% | 465.65% | 663.30% | 205.56% | 166.10% |
| SG&A Expenses | -8.24% | -3.24% | -0.21% | 4.57% | 9.17% |
| Depreciation & Amortization | 111.37% | -65.44% | -55.76% | -66.53% | -4.74% |
| Other Operating Expenses | -- | -- | -- | -- | -63.35% |
| Total Operating Expenses | -43.54% | -22.90% | 1.36% | 33.22% | 97.25% |
| Operating Income | 47.80% | 44.40% | 45.63% | 39.30% | 43.10% |
| Income Before Tax | 37.17% | 48.68% | 34.97% | 45.24% | 42.23% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 37.17% | 48.68% | 34.97% | 45.24% | 42.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.17% | 48.68% | 34.97% | 45.24% | 42.23% |
| EBIT | 47.80% | 44.40% | 45.63% | 39.30% | 43.10% |
| EBITDA | 48.07% | 44.52% | 45.80% | 39.40% | 43.35% |
| EPS Basic | 37.69% | 51.72% | 39.84% | 51.92% | 50.33% |
| Normalized Basic EPS | 48.24% | 48.01% | 35.51% | 48.57% | 46.92% |
| EPS Diluted | 37.69% | 51.72% | 39.84% | 51.92% | 50.33% |
| Normalized Diluted EPS | 48.24% | 48.01% | 35.51% | 48.57% | 46.92% |
| Average Basic Shares Outstanding | 0.82% | 3.76% | 7.26% | 11.32% | 17.62% |
| Average Diluted Shares Outstanding | 0.82% | 3.76% | 7.26% | 11.32% | 17.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
